Morgan Stanley’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Morgan Stanley’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-233,885	Closed	-$10.7M	–	6967
2015 Q1	$10.7M	Buy	233,885 +66,191	+39%	+$1.98M	﹤0.01%	1984
2014 Q4	$4.03M	Buy	167,694 +78,815	+89%	+$1.78M	﹤0.01%	2932
2014 Q3	$2.24M	Buy	88,879 +20,174	+29%	+$501K	﹤0.01%	3331
2014 Q2	$1.79M	Buy	68,705 +58,658	+584%	+$1.51M	﹤0.01%	3566
2014 Q1	$259K	Buy	10,047 +7,064	+237%	+$191K	﹤0.01%	4977
2013 Q4	$60K	Buy	+2,983	New	+$70.2K	﹤0.01%	5535

Morgan Stanley's HPTX Position: Q2 2015 in Review

Morgan Stanley sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 233,885 shares — an estimated $10.7M sold.

Morgan Stanley first reported a position in HPTX in Q4 2013 and held it in 6 quarters. The position peaked at $10.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Morgan Stanley reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Morgan Stanley sold 233,885 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $10.7M.
Morgan Stanley first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 6 quarters.
Morgan Stanley's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $10.7M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.